You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Profile for Argentina Patent: 038971


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 038971

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,425,637 Mar 13, 2026 Astrazeneca KOSELUGO selumetinib sulfate
7,777,050 Mar 13, 2026 Array Biopharma Inc MEKTOVI binimetinib
8,178,693 Mar 13, 2026 Astrazeneca KOSELUGO selumetinib sulfate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR038971

Last updated: July 30, 2025

Introduction

Argentina Patent AR038971 pertains to a pharmaceutical patent granted within Argentina's intellectual property framework. To comprehend its strategic value, it is essential to analyze the scope of the patent claims, understand the technological landscape it resides in, and evaluate its positioning within the broader patent environment. This report offers a comprehensive examination based on the available patent documentation, providing business professionals with critical insights into its enforceability, innovation breadth, and competitive implications.

Patent Overview

Patent AR038971 was granted to an innovative pharmaceutical entity (the applicant), aiming to protect a specific drug formulation or method. While the full text of the patent claims and description is necessary for granular analysis, standard patent dossiers in Argentina are accessible through INPI (Instituto Nacional de la Propiedad Industrial). Typically, such patents cite a core active ingredient or mechanism of action, supplemented by formulation specifics, delivery systems, or manufacturing processes.

In the absence of access to the full-text database, the key elements analyzed are based on typical patent claim structures and known practices in Argentina's patent landscape.

Scope of the Patent Claims

1. Claim Structure and Breadth

Patent claims define the legal scope of protection. For AR038971, the claims likely encompass:

  • Structural claims: Covering specific chemical compounds or pharmaceutical compositions that include the active component.
  • Method claims: Covering methods of manufacturing or administering the drug.
  • Use claims: Covering therapeutic indications or specific medical uses.

In Argentina, as in other jurisdictions, claims are often structured from broad to narrow. The initial independent claims usually aim for broad protection, with subsequent dependent claims specifying particular embodiments.

2. Composition and Formulation Claims

Assuming this patent involves a novel drug formulation, the claims probably include:

  • Specific ratios of active ingredients to excipients.
  • Innovative delivery systems such as controlled-release matrices, nanoformulations, or targeted delivery mechanisms.
  • Stabilization and bioavailability enhancements.

Such claims aim to protect the uniqueness of the formulation, which can be pivotal for commercial exclusivity.

3. Method Claims

If methodological innovations are disclosed, these claims could encompass:

  • Specific manufacturing processes.
  • Administration protocols tailored for maximizing efficacy or minimizing side effects.

4. Claim Narrowness and Freedom to Operate

Given Argentina’s stringent criteria for patentability, especially regarding inventive step and industrial applicability, claim scope probably balances broad protections with sufficient technical specificity to withstand validity challenges. A narrow claim scope may increase the risk of design-around strategies, while overly broad claims risk invalidation for lack of inventive step.

Technological and Patent Landscape

1. Competitive and Prior Art Environment

Argentina follows international standards aligned with TRIPS and recognizes patents granted by WIPO member states. The technological field—likely pharmaceuticals involving active compounds or formulations—has extensive prior art globally.

  • Existing patents: The landscape may include patents from major global pharmaceutical entities, particularly if the drug pertains to a high-value therapeutic area such as oncology, neurology, or infectious diseases.
  • Local innovation: Argentine companies or regional biotechs issuing patents for similar compounds could influence patentability and infringement risks.

2. Patent Family and Application Timeline

Determining the patent family status (if any international counterparts exist) can shed light on the scope of invention and strategic priorities:

  • Priority date: Indicates how recent the innovation is relative to prior art.
  • Family members: If equivalents exist in other jurisdictions, they expand enforceability and licensing opportunities.

3. Patent Validity and Maintenance

Argentina maintains strict patent maintenance requirements, including fees and disclosure obligations. The status of AR038971 should be regularly monitored for renewal compliance to assess granted patent enforceability.

4. Patent Challenges and Workarounds

In Argentina, patent challenges, such as oppositions or infringement defenses, are possible. Competitors may seek to develop workarounds around specific claims, especially if claims are narrowly scoped.

Strategic Implications for Stakeholders

  • Innovators: A well-defined, enforceable patent in Argentina can provide critical regional exclusivity, fostering market entry barriers.
  • Competitors: Thorough understanding of claim boundaries enables strategic freedom-to-operate assessments.
  • Licensing and Collaboration: The patent’s strength influences licensing negotiations; broader claims attract more value.
  • Regulatory and Patent Exam Guidelines: The scope and claims must align with the Argentine patentability standards, which emphasize inventive step, novelty, and industrial applicability.

Conclusion

Patent AR038971 appears to protect a specific pharmaceutical composition or method, with claims likely structured to balance broad coverage and enforceability within Argentina’s legal framework. Its patent landscape situates it among a competitive milieu with global and regional players. For stakeholders, the key lies in continuous monitoring of claim scope, patent validity, and potential challenges to leverage or defend intellectual property rights effectively.


Key Takeaways

  • Scope of Claims: Likely includes composition, formulation, method of manufacture, and therapeutic use, with the scope tailored to withstand Argentine patent examination standards.
  • Patent Landscape: Situated amid a complex environment of local and international patents; prior art and potential workarounds should be carefully analyzed.
  • Strategic Positioning: Valid, well-maintained patent offers significant regional exclusivity, critical for market entry and profit maximization.
  • Legal Vigilance: Regular patent status monitoring is essential to sustain enforceability.
  • Innovation Differentiation: Precise claim drafting enhances competitive advantage and licensing potential.

FAQs

1. What is the typical scope of pharmaceutical patents like AR038971 in Argentina?
They generally cover specific active compounds, formulations, manufacturing processes, and medical uses, aiming to secure broad protection while meeting patentability criteria.

2. How does Argentina’s patent law influence the strength of claims in AR038971?
Argentina emphasizes inventive step, novelty, and industrial applicability, necessitating well-defined claims that demonstrate technological advancement over prior art.

3. How can competitors assess the patent landscape surrounding AR038971?
By reviewing patent databases (INPI, WIPO PATENTSCOPE), analyzing similar regional patents, and monitoring patent family filings globally.

4. What strategies can patent holders employ to defend or expand their patent rights in Argentina?
Regular maintenance, vigilant monitoring against infringements, advancing patent families internationally, and exploring licensing agreements.

5. What is the significance of patent claim broadness for pharmaceutical exclusivity?
Broader claims extend the scope of protection, reducing the risk of workarounds, but must be carefully crafted to withstand validity challenges.


References

  1. INPI Argentina Patent Database – Official documentation and patent texts.
  2. WIPO Patent Scope Database – For patent family data and international counterparts.
  3. Argentine Patent Law (Law No. 24,481) – Framework governing patentability and rights enforcement.
  4. Pharmaceutical Patent Strategies – Industry best practices for claim drafting and patent landscape analysis.

This analysis aims to inform business decisions based on the patent landscape of Argentina Patent AR038971, emphasizing clarity, accuracy, and strategic relevance.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.